 | • レポートコード：MRC2312MG08878 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学＆材料 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のペプチドAPI市場規模と予測を収録しています。・世界のペプチドAPI市場：売上、2018年-2023年、2024年-2029年 ・世界のペプチドAPI市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のペプチドAPI市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ホルモンポリスキン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ペプチドAPIのグローバル主要企業は、AmbioPharm、 CordenPharma、 Dr. Reddy's、 Bachem、 Peptide Institute, Inc.、 PeptiStar、 Piramal Pharma、 Biosynth、 Smaart Pharmaceutticals、 Creative Peptides、 CPC Scientific、 KS-V、 Shenzhen Hanyu Pharmaceutical、 Shuangcheng Pharma、 Chengdu Shengnuo Biopharm Co.,Ltdなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ペプチドAPIのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のペプチドAPI市場：タイプ別、2018年-2023年、2024年-2029年 世界のペプチドAPI市場：タイプ別市場シェア、2022年 ・ホルモンポリスキン、抗体ポリペプチド、成長因子ポリペプチド、神経調節ポリペプチド、抗菌ペプチド 世界のペプチドAPI市場：用途別、2018年-2023年、2024年-2029年 世界のペプチドAPI市場：用途別市場シェア、2022年 ・抗悪性腫瘍薬、免疫系薬、消化器系薬、糖尿病薬、整形外科用薬、産科薬、その他 世界のペプチドAPI市場：地域・国別、2018年-2023年、2024年-2029年 世界のペプチドAPI市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるペプチドAPIのグローバル売上、2018年-2023年 ・主要企業におけるペプチドAPIのグローバル売上シェア、2022年 ・主要企業におけるペプチドAPIのグローバル販売量、2018年-2023年 ・主要企業におけるペプチドAPIのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 AmbioPharm、 CordenPharma、 Dr. Reddy's、 Bachem、 Peptide Institute, Inc.、 PeptiStar、 Piramal Pharma、 Biosynth、 Smaart Pharmaceutticals、 Creative Peptides、 CPC Scientific、 KS-V、 Shenzhen Hanyu Pharmaceutical、 Shuangcheng Pharma、 Chengdu Shengnuo Biopharm Co.,Ltd ************************************************************* ・調査・分析レポートの概要 ペプチドAPI市場の定義 市場セグメント 世界のペプチドAPI市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のペプチドAPI市場規模 世界のペプチドAPI市場規模：2022年 VS 2029年 世界のペプチドAPI市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのペプチドAPIの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のペプチドAPI製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ホルモンポリスキン、抗体ポリペプチド、成長因子ポリペプチド、神経調節ポリペプチド、抗菌ペプチド ペプチドAPIのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：抗悪性腫瘍薬、免疫系薬、消化器系薬、糖尿病薬、整形外科用薬、産科薬、その他 ペプチドAPIの用途別グローバル売上・予測 ・地域別市場分析 地域別ペプチドAPI市場規模 2022年と2029年 地域別ペプチドAPI売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） AmbioPharm、 CordenPharma、 Dr. Reddy's、 Bachem、 Peptide Institute, Inc.、 PeptiStar、 Piramal Pharma、 Biosynth、 Smaart Pharmaceutticals、 Creative Peptides、 CPC Scientific、 KS-V、 Shenzhen Hanyu Pharmaceutical、 Shuangcheng Pharma、 Chengdu Shengnuo Biopharm Co.,Ltd ... |
This research report provides a comprehensive analysis of the Peptide API market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Peptide API market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Peptide API, challenges faced by the industry, and potential opportunities for market players.
The global Peptide API market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Peptide API market presents opportunities for various stakeholders, including Antineoplastic Drugs, Immune System Drugs. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Peptide API market. Additionally, the growing consumer demand present avenues for market expansion.
The global Peptide API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Peptide API market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Peptide API market.
Market Overview: The report provides a comprehensive overview of the Peptide API market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Hormonal Polyskin, Antibody Polypeptide), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Peptide API market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Peptide API market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Peptide API market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Peptide API market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Peptide API market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Peptide API market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Peptide API, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Peptide API market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Peptide API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Hormonal Polyskin
Antibody Polypeptide
Growth Factor Polypeptide
Neuromodulatory Polypeptide
Antibacterial Peptides
Market segment by Application
Antineoplastic Drugs
Immune System Drugs
Digestive System Drugs
Diabetes Drugs
Orthopedic Drugs
Obstetric Drugs
Others
Global Peptide API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
AmbioPharm
CordenPharma
Dr. Reddy’s
Bachem
Peptide Institute, Inc.
PeptiStar
Piramal Pharma
Biosynth
Smaart Pharmaceutticals
Creative Peptides
CPC Scientific
KS-V
Shenzhen Hanyu Pharmaceutical
Shuangcheng Pharma
Chengdu Shengnuo Biopharm Co.,Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptide API, market overview.
Chapter 2: Global Peptide API market size in revenue and volume.
Chapter 3: Detailed analysis of Peptide API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Peptide API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Peptide API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptide API Overall Market Size
2.1 Global Peptide API Market Size: 2022 VS 2029
2.2 Global Peptide API Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Peptide API Sales: 2018-2029
3 Company Landscape
3.1 Top Peptide API Players in Global Market
3.2 Top Global Peptide API Companies Ranked by Revenue
3.3 Global Peptide API Revenue by Companies
3.4 Global Peptide API Sales by Companies
3.5 Global Peptide API Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Peptide API Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Peptide API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptide API Players in Global Market
3.8.1 List of Global Tier 1 Peptide API Companies
3.8.2 List of Global Tier 2 and Tier 3 Peptide API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Peptide API Market Size Markets, 2022 & 2029
4.1.2 Hormonal Polyskin
4.1.3 Antibody Polypeptide
4.1.4 Growth Factor Polypeptide
4.1.5 Neuromodulatory Polypeptide
4.1.6 Antibacterial Peptides
4.2 By Type – Global Peptide API Revenue & Forecasts
4.2.1 By Type – Global Peptide API Revenue, 2018-2023
4.2.2 By Type – Global Peptide API Revenue, 2024-2029
4.2.3 By Type – Global Peptide API Revenue Market Share, 2018-2029
4.3 By Type – Global Peptide API Sales & Forecasts
4.3.1 By Type – Global Peptide API Sales, 2018-2023
4.3.2 By Type – Global Peptide API Sales, 2024-2029
4.3.3 By Type – Global Peptide API Sales Market Share, 2018-2029
4.4 By Type – Global Peptide API Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Peptide API Market Size, 2022 & 2029
5.1.2 Antineoplastic Drugs
5.1.3 Immune System Drugs
5.1.4 Digestive System Drugs
5.1.5 Diabetes Drugs
5.1.6 Orthopedic Drugs
5.1.7 Obstetric Drugs
5.1.8 Others
5.2 By Application – Global Peptide API Revenue & Forecasts
5.2.1 By Application – Global Peptide API Revenue, 2018-2023
5.2.2 By Application – Global Peptide API Revenue, 2024-2029
5.2.3 By Application – Global Peptide API Revenue Market Share, 2018-2029
5.3 By Application – Global Peptide API Sales & Forecasts
5.3.1 By Application – Global Peptide API Sales, 2018-2023
5.3.2 By Application – Global Peptide API Sales, 2024-2029
5.3.3 By Application – Global Peptide API Sales Market Share, 2018-2029
5.4 By Application – Global Peptide API Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Peptide API Market Size, 2022 & 2029
6.2 By Region – Global Peptide API Revenue & Forecasts
6.2.1 By Region – Global Peptide API Revenue, 2018-2023
6.2.2 By Region – Global Peptide API Revenue, 2024-2029
6.2.3 By Region – Global Peptide API Revenue Market Share, 2018-2029
6.3 By Region – Global Peptide API Sales & Forecasts
6.3.1 By Region – Global Peptide API Sales, 2018-2023
6.3.2 By Region – Global Peptide API Sales, 2024-2029
6.3.3 By Region – Global Peptide API Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Peptide API Revenue, 2018-2029
6.4.2 By Country – North America Peptide API Sales, 2018-2029
6.4.3 US Peptide API Market Size, 2018-2029
6.4.4 Canada Peptide API Market Size, 2018-2029
6.4.5 Mexico Peptide API Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Peptide API Revenue, 2018-2029
6.5.2 By Country – Europe Peptide API Sales, 2018-2029
6.5.3 Germany Peptide API Market Size, 2018-2029
6.5.4 France Peptide API Market Size, 2018-2029
6.5.5 U.K. Peptide API Market Size, 2018-2029
6.5.6 Italy Peptide API Market Size, 2018-2029
6.5.7 Russia Peptide API Market Size, 2018-2029
6.5.8 Nordic Countries Peptide API Market Size, 2018-2029
6.5.9 Benelux Peptide API Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Peptide API Revenue, 2018-2029
6.6.2 By Region – Asia Peptide API Sales, 2018-2029
6.6.3 China Peptide API Market Size, 2018-2029
6.6.4 Japan Peptide API Market Size, 2018-2029
6.6.5 South Korea Peptide API Market Size, 2018-2029
6.6.6 Southeast Asia Peptide API Market Size, 2018-2029
6.6.7 India Peptide API Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Peptide API Revenue, 2018-2029
6.7.2 By Country – South America Peptide API Sales, 2018-2029
6.7.3 Brazil Peptide API Market Size, 2018-2029
6.7.4 Argentina Peptide API Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Peptide API Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Peptide API Sales, 2018-2029
6.8.3 Turkey Peptide API Market Size, 2018-2029
6.8.4 Israel Peptide API Market Size, 2018-2029
6.8.5 Saudi Arabia Peptide API Market Size, 2018-2029
6.8.6 UAE Peptide API Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AmbioPharm
7.1.1 AmbioPharm Company Summary
7.1.2 AmbioPharm Business Overview
7.1.3 AmbioPharm Peptide API Major Product Offerings
7.1.4 AmbioPharm Peptide API Sales and Revenue in Global (2018-2023)
7.1.5 AmbioPharm Key News & Latest Developments
7.2 CordenPharma
7.2.1 CordenPharma Company Summary
7.2.2 CordenPharma Business Overview
7.2.3 CordenPharma Peptide API Major Product Offerings
7.2.4 CordenPharma Peptide API Sales and Revenue in Global (2018-2023)
7.2.5 CordenPharma Key News & Latest Developments
7.3 Dr. Reddy’s
7.3.1 Dr. Reddy’s Company Summary
7.3.2 Dr. Reddy’s Business Overview
7.3.3 Dr. Reddy’s Peptide API Major Product Offerings
7.3.4 Dr. Reddy’s Peptide API Sales and Revenue in Global (2018-2023)
7.3.5 Dr. Reddy’s Key News & Latest Developments
7.4 Bachem
7.4.1 Bachem Company Summary
7.4.2 Bachem Business Overview
7.4.3 Bachem Peptide API Major Product Offerings
7.4.4 Bachem Peptide API Sales and Revenue in Global (2018-2023)
7.4.5 Bachem Key News & Latest Developments
7.5 Peptide Institute, Inc.
7.5.1 Peptide Institute, Inc. Company Summary
7.5.2 Peptide Institute, Inc. Business Overview
7.5.3 Peptide Institute, Inc. Peptide API Major Product Offerings
7.5.4 Peptide Institute, Inc. Peptide API Sales and Revenue in Global (2018-2023)
7.5.5 Peptide Institute, Inc. Key News & Latest Developments
7.6 PeptiStar
7.6.1 PeptiStar Company Summary
7.6.2 PeptiStar Business Overview
7.6.3 PeptiStar Peptide API Major Product Offerings
7.6.4 PeptiStar Peptide API Sales and Revenue in Global (2018-2023)
7.6.5 PeptiStar Key News & Latest Developments
7.7 Piramal Pharma
7.7.1 Piramal Pharma Company Summary
7.7.2 Piramal Pharma Business Overview
7.7.3 Piramal Pharma Peptide API Major Product Offerings
7.7.4 Piramal Pharma Peptide API Sales and Revenue in Global (2018-2023)
7.7.5 Piramal Pharma Key News & Latest Developments
7.8 Biosynth
7.8.1 Biosynth Company Summary
7.8.2 Biosynth Business Overview
7.8.3 Biosynth Peptide API Major Product Offerings
7.8.4 Biosynth Peptide API Sales and Revenue in Global (2018-2023)
7.8.5 Biosynth Key News & Latest Developments
7.9 Smaart Pharmaceutticals
7.9.1 Smaart Pharmaceutticals Company Summary
7.9.2 Smaart Pharmaceutticals Business Overview
7.9.3 Smaart Pharmaceutticals Peptide API Major Product Offerings
7.9.4 Smaart Pharmaceutticals Peptide API Sales and Revenue in Global (2018-2023)
7.9.5 Smaart Pharmaceutticals Key News & Latest Developments
7.10 Creative Peptides
7.10.1 Creative Peptides Company Summary
7.10.2 Creative Peptides Business Overview
7.10.3 Creative Peptides Peptide API Major Product Offerings
7.10.4 Creative Peptides Peptide API Sales and Revenue in Global (2018-2023)
7.10.5 Creative Peptides Key News & Latest Developments
7.11 CPC Scientific
7.11.1 CPC Scientific Company Summary
7.11.2 CPC Scientific Business Overview
7.11.3 CPC Scientific Peptide API Major Product Offerings
7.11.4 CPC Scientific Peptide API Sales and Revenue in Global (2018-2023)
7.11.5 CPC Scientific Key News & Latest Developments
7.12 KS-V
7.12.1 KS-V Company Summary
7.12.2 KS-V Business Overview
7.12.3 KS-V Peptide API Major Product Offerings
7.12.4 KS-V Peptide API Sales and Revenue in Global (2018-2023)
7.12.5 KS-V Key News & Latest Developments
7.13 Shenzhen Hanyu Pharmaceutical
7.13.1 Shenzhen Hanyu Pharmaceutical Company Summary
7.13.2 Shenzhen Hanyu Pharmaceutical Business Overview
7.13.3 Shenzhen Hanyu Pharmaceutical Peptide API Major Product Offerings
7.13.4 Shenzhen Hanyu Pharmaceutical Peptide API Sales and Revenue in Global (2018-2023)
7.13.5 Shenzhen Hanyu Pharmaceutical Key News & Latest Developments
7.14 Shuangcheng Pharma
7.14.1 Shuangcheng Pharma Company Summary
7.14.2 Shuangcheng Pharma Business Overview
7.14.3 Shuangcheng Pharma Peptide API Major Product Offerings
7.14.4 Shuangcheng Pharma Peptide API Sales and Revenue in Global (2018-2023)
7.14.5 Shuangcheng Pharma Key News & Latest Developments
7.15 Chengdu Shengnuo Biopharm Co.,Ltd
7.15.1 Chengdu Shengnuo Biopharm Co.,Ltd Company Summary
7.15.2 Chengdu Shengnuo Biopharm Co.,Ltd Business Overview
7.15.3 Chengdu Shengnuo Biopharm Co.,Ltd Peptide API Major Product Offerings
7.15.4 Chengdu Shengnuo Biopharm Co.,Ltd Peptide API Sales and Revenue in Global (2018-2023)
7.15.5 Chengdu Shengnuo Biopharm Co.,Ltd Key News & Latest Developments
8 Global Peptide API Production Capacity, Analysis
8.1 Global Peptide API Production Capacity, 2018-2029
8.2 Peptide API Production Capacity of Key Manufacturers in Global Market
8.3 Global Peptide API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Peptide API Supply Chain Analysis
10.1 Peptide API Industry Value Chain
10.2 Peptide API Upstream Market
10.3 Peptide API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peptide API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
